Logo

Protect Animal Health and DotBio Join Forces to Develop Therapies and Technologies for Companion Animals

Share this

Protect Animal Health and DotBio Join Forces to Develop Therapies and Technologies for Companion Animals

Shots:

  • Protect Animal Health (PAH) & DotBio have entered into a strategic partnership for developing an antibody discovery platform & new therapeutic antibody portfolio to improve the quality of life in companion animals, specifically, dogs & cats
  • The partnership will employ DotBio’s DotBodies platform & intracellular antibody technology for developing therapeutic antibodies addressing diseases in canine & feline populations
  • Both will further identify & optimize high-affinity, multi-specific antibodies, for treating autoimmune diseases, cancers & chronic inflammatory disorders

Ref: Protect Animal Health and DotBio | Image: Protect Animal Health and DotBio

Related News:- Merck Animal Health’s Innovax-ND-H5 Vaccine Gains the EC’s Marketing Authorization for Chickens

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com

Click here to­ read the full press release 

Disha Nankani

Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions